How it may work
An experimental long-acting GHRH analogue studied for effects on growth-hormone signalling.
Guide-level evidence orientationEvidence level E
Level E marks a central question without dependable direct human evidence; read the outcome conclusion rather than treating the letter as a direction of effect.
This guide-level grade is an orientation, not a direction-of-effect label, product grade, claim or personal recommendation.Why people are interested
An experimental peptide designed to extend growth-hormone-releasing signals. Reliable healthy-ageing or recovery benefits have not been demonstrated.
Library trackMedical research
Last reviewed20 Aug 2026
Guide scopeIngredient research only
What people have studied
There is no established controlled evidence supporting consumer longevity or recovery use.
What to consider
Endocrine, metabolic and product-quality risks make self-experimentation inappropriate.
Local pathway
Research/medical content only. Not sold by CELLIVITY.
Sources + indexes
See where the explanation comes from.
Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.